IP
Ironwood Pharmaceuticals Inc
🇩🇪XFRA.I76GermanyHealthcare
€3.40EURdown -0.04 (-1.16%)OpenEnd of day5:13 PM
Price€3.40-0.04 (-1.16%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US46333X1081
- CUSIP
- Not reported
Company
- Employees
- 100
- Headquarters
- Boston, United States
- Website
- https://ironwoodpharma.com
- CEO
- Mr. Thomas A. McCourt
Market
- Shares outstanding
- 163.1M
- Market cap
- €554.4M
Highlights
- Market cap
- €554.4M
- EPS LTM
- $0.78
- P/E LTM
- 5.35
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $389.32M+26.19%up year on year
- Net income
- $129.87M+1,747.03%up year on year
- Gross margin
- 99.65%+78.41%up year on year
- Free cash flow
- $185.55M+519.84%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.